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ABSTRACT
The 5’ untranslated region of the FMR1 gene which
normally includes 4–55d(CGG) repeats expands to
>55–200 repeats in carriers of fragile X syndrome
premutation. Although the levels of premutation
FMR1 mRNA in carrier cells are 5–10-fold higher
than normal, the amount of the product FMR protein
is unchanged or reduced. We demonstrated pre-
viously that premutation r(CGG)n tracts formed
quadruplex structures that impeded translation
and lowered the efficiency of protein synthesis.
Normal translation could be restored in vivo by the
quadruplex r(CGG)n destabilizing action of CBF-A
and hnRNP A2 proteins. Here we report that the
quadruplex-interacting cationic porphyrin TMPyP4
by itself and in cooperation with CBF-A or hnRNP
A2 also unfolded quadruplex r(CGG)n and increased
the efficiency of translation of 5’-(CGG)99 containing
reporter firefly (FL) mRNA. TMPyP4 destabilized
in vitro a (CGG)33 intramolecular quadruplex struc-
ture and enhanced the translation of 5’-(CGG)99-FL
mRNA in a rabbit reticulocyte lysate and in HEK293
cells. The efficiency of translation of (CGG)99-FL
mRNA was additively increased in cells exposed
to TMPyP4 together with CBF-A. Whereas low
doses of TMPyP4, CBF-A or hnRNP A2 by them-
selves did not affect the in vivo utilization of
(CGG)99-FL mRNA, introduction of TMPyP4 together
with either protein synergistically augmented its
translation efficiency.
INTRODUCTION
The 50 untranslated region (UTR) of the ﬁrst exon of the
FMR1 gene includes in normal humans 4–55 repeats of a
d(CGG) trinucleotide. Dynamic mutation that expands
the d(CGG)n sequence to >200–2000 repeats sets oﬀ frag-
ile X syndrome (FXS), the most common cause of inher-
ited mental retardation (1,2). Following its massive
expansion, the repeat tract and an adjacent CpG island
become hypermethylated and associated histones are
modiﬁed such that FMR1 is silenced and its FMRP prod-
uct protein is not synthesized (3). While not developing
FXS, carriers of FMR1 premutation alleles that have
>55–200d(CGG) repeats do present diverse clinical invol-
vements (4,5). Most prominently, about 20% of the pre-
mutation female carriers exhibit premature ovarian failure
(POF) (4,6) and up to one-third of the male carriers of a
premutation allele present fragile X associated tremor-
ataxia syndrome (FXTAS) (7–9).
Notably, in contrast to the absence of FMR1 transcripts
in FXS cells, peripheral blood leukocytes that have
(CGG)100–200 premutation repeats produce 5–10-fold
higher amounts of FMR1 mRNA than cells of normal
human subjects (10–12). A similar accumulation of
excess mRNA was also observed in a mouse premutation
model (13). Yet, despite the excessive amounts of FMR1
transcripts, levels of their product protein FMRP remain
unchanged or are lower than normal in cells of premuta-
tion carriers (11,14). The apparent reduced eﬃciency
of translation of FMR1 mRNA is consistent with a
reported diminished association of premutation FMR1
mRNA with polysomes in lymphoblastoid cell lines (14).
Similarly, despite their normal steady-state level of FMR1
mRNA, cells of a mildly aﬀected FXS individual with
FMR1 alleles that included more than 200 (CGG) repeats
displayed markedly reduced FMRP synthesis. Moreover,
the FMR1 mRNA molecules in these cells were shown to
be associated with stalled 40S ribosomal subunits (15). Put
together, the gathered evidence suggested that hindered
polysome formation and stalled ribosome progression
along premutation FMR1 mRNA result in decreased eﬃ-
ciency of its translation in vivo. A likely source of the
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(CGG)n premutation RNA tract into secondary struc-
tures. Such structures may well hamper the formation
of polysomes and diminish the productive migration of
ribosomes along the mRNA. Indeed, (CGG) repeat
sequences in RNA were shown to readily fold into hairpin
structures (16,17) and to form intra- and intermolecular
tetraplexes (18,19). Translation has been shown to be
impeded by quadruplex structures in diverse mRNA mole-
cules (20–22). More pertinently, we reported that premu-
tation (CGG) repeats placed in the 50 UTR region of a
ﬁreﬂy luciferase (FL) reporter gene fold in FL mRNA
transcripts into quadruplex structures that decreased the
eﬃciency of their translation in vitro and in vivo.
Moreover, two member proteins of the hnRNP family,
CBF-A and hnRNP A2, that destabilize quadruplex
(CGG)n were demonstrated to alleviate in living cells the
impediment to translation (19). Overall, these results
strongly suggested that by folding into tetraplex struc-
tures, the 50 UTR premutation (CGG)n sequence in
mRNA obstructs translation and that the resolution of
the tetrahelical secondary structure can restore protein
synthesis to its normal level.
Reinstating normal eﬃciency of FMR1 mRNA transla-
tion in FX carrier cells can conceivably assuage some of
the clinical sequelae of the FMR1 premutation. However,
exogenously introduced proteins such as CBF-A or
hnRNP A2 that resolve secondary structures in mRNA
are unlikely to become therapeutically applicable.
Rather, a more viable approach is the use of low molecu-
lar size tetraplex unfolding agents. The cationic porphyrin
5,10,15,20-tetra(N-methyl-4-pyridyl)porphin (TMPyP4)
whose size and geometry approximate those of a guanine
quartet, was shown to selectively interact with and stabi-
lize quadruplex structures formed by the guanine-rich
sequences of telomeric DNA or within the NHE III1
promoter of c-MYC (23,24). Conversely, however, this
cationic porphyrin eﬀectively destabilized in vitro G02
bimolecular tetraplex structure of (CGG)n in DNA and
RNA (25). Owing to its quadruplex (CGG)n disrupting
activity, TMPyP4 might potentially serve as a model
low molecular size agent that may increase the translation
eﬃciency of premutation FMR1 mRNA. Yet, being a
charged molecule, TMPyP4 is unlikely to cross the
blood–brain barrier and it thus cannot eﬀectively treat
neurodevelopmental disorders such as FXTAS. Use of
this cationic porphyrin to destabilize d/r(CGG)n quadru-
plexes in vivo constitutes, therefore, a proof of principle
rather than identiﬁcation of a clinically applicable thera-
peutic agent.
In this work we demonstrate that TMPyP4 unfolded
tetraplex RNA (CGG)n in vitro and enhanced the transla-
tion of 50 UTR (CGG)99-FL mRNA in a reticulocyte
lysate system. TMPyP4 that was added to HEK293 cells
at excess over 50 UTR (CGG)99-FL mRNA increased the
eﬃciency of its translation. When introduced at a low
ratio relative to the premutation mRNA, the cationic por-
phyrin failed to aﬀect by itself the eﬃciency of translation.
However, TMPyP4 together with sub-saturating amounts
of either CBF-A or hnRNP A2 cooperatively augmented
the eﬃciently of the in vivo translation of 50 UTR
(CGG)99-FL mRNA. Potential therapeutic implications
of these ﬁndings are discussed.
MATERIALS AND METHODS
Cationicporphyrins
The cationic porphyrin 5,10,15,20-tetra(N-methyl-
4-pyridyl)porphin (TMPyP4) was the product of
Calbiochem. Its two isomers 5,10,15,20-tetra(N-methyl-
3-pyridyl)porphin (TMPyP3) and 5,10,15,20-tetra
(N-methyl-2-pyridyl)porphin (TMPyP2) were the gener-
ous gift of Dr Lawrence H. Hurley (University of
Arizona). Because of their photolability, stock solutions
of 1.0mM of each porphyrin in water were stored in
opaque tubes at –708C and diluted and used in the dark
for in vitro or in vivo experiments. We established that the
in vivo application of TMPyP4 at all its speciﬁed concen-
trations and under every described experimental condition
did not aﬀect cell viability or growth rate.
Plasmids
Plasmids: pT7-FMR1-50-UTR(CGG)n-FL (n=30 or 99);
pCS107; pCS107(CGG)33;p FMR1-50-UTR(CGG)n-FL
(n=0, 30 or 99); pCMV2-Flag; pCMV2-Flag-CBF-A
and pCMV2-Flag-hnRNP A2 vectors that harbored
genes that encode the quadruplex destabilizing proteins
CBF-A and hnRNP A2, respectively, and a pCMV-RL
plasmid (Promega) that encodes Renilla reniformis lucifer-
ase under the control of a CMV promoter were prepared
and propagated as we recently detailed (19).
Electrophoretic resolutionof 5’-
32PpCS107(CGG)33 RNA
Total 1.0mg of BstX1 linearized pCS107(CGG)33was tran-
scribed in vitro at 378C for 2h in AmpliScribe SP6 system
(Epicenter Biotechnologies) according to the manufac-
turer’s instructions in a reaction mixture that contained
0.3mCi [a-
32P]-UTP (3000Ci/mmol). The reaction was
terminated by the addition of SDS to a ﬁnal concentration
of 0.5%, and the product RNA was ethanol precipitated
and washed as described (19). The air-dried RNA precip-
itate was suspended in 25mM Tris–HCl buﬀer, pH 8.0
that contained 0.5mM DTT, 1.0mM EDTA and 20%
glycerol. Following heating at 658C for 3min, cooling at
48C for 2min and incubation in the dark at room tem-
perature for 10min in the presence or absence of 20mM
KCl or LiCl and without or with 1.6mM TMPyP4,
RNA aliquots of equal radioactivity were resolved in the
dark by electrophoresis through a nondenaturing 0.6%
agarose gel. Positions of the migrating RNA samples rel-
ative to a
32P-labelled RNA transcript of EcoR1 linearized
pCS107 that was devoid of the (CGG)33 tract, were
identiﬁed by exposure of the dried gels to phosphor
imager plates.
Translationin vitro
pT7-FMR1-50-UTR(CGG)n-FL plasmids (n=30 or 99)
were linearized by Xba cleavage and transcribed at
378C for 90min in an AmpliScribe
TM T7-Flash
TM Tran-
scription kit (Epicentre Technologies) according to the
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template DNA by digestion at 378C for 15min with
RNase free DNase (Promega), the product RNA was
extracted with phenol:chloroform:isoamyl alcohol
(25:24:1) followed by chloroform extraction and ethanol
precipitation. The centrifuged and air-dried RNA pellet
was resuspended in RNase-free water and its amount
was determined by electrophoretic resolution side-by-side
with known amounts of tRNA. Aliquots of 0.5mg RNA
that included 30 or 99 50 (CGG) repeats were translated
in vitro in a mixture that contained in a ﬁnal volume of
25ml: 12.5ml rabbit reticulocyte lysate (Flexi translation
system, Promega), 20mM amino acids mixture, 2.0mM
DTT; 1.0mM magnesium acetate; 70mM KCl and 20
units of ribonuclease inhibitor (Takara) without or in
the presence of increasing amounts of TMPyP4,
TMPyP3 or TMPyP2. The mixtures were incubated at
308C for 90–120min and the translation reaction was ter-
minated by rapid cooling of the samples to 48C. FL activ-
ity was measured in 10ml aliquots in a Glomax 20/20
luminometer (Promega) as we described (19).
Transfectionof cultured human cells
Human Embryonic Kidney 293 (HEK293) cells were
seeded in 0.1% gelatin-coated 10cm plates and grown to
80–90% conﬂuence at 378C and in 5% CO2 atmosphere in
Dulbecco Modiﬁed Eagle’s Medium (DMEM) supple-
mented with 4.5g/l D-glucose, 5.0mM L-glutamine, 10%
fetal calf serum, 83.3U/ml each of penicillin and strepto-
mycin and 0.2mg/ml Amphotericin B (Biological
Industries, Israel). The cells were detached by Trypsin–
EDTA, reseeded in gelatin-coated 6-well plates at
3 10
5 to 5 10
5cells/well and immediately co-trans-
fected with three plasmids: pFMR1-50-UTR(CGG)n-FL
(n=0, 30 or 99) that harbored ﬁreﬂy luciferase (FL)
reporter gene without or with 50-(CGG)30 or (CGG)99
repeat tracts; pCMV-RL normalizing reporter vector
and pCMV2-Flag-CBF-A or pCMV2-Flag-hnRNP A2
plasmids that expressed the quadruplex destabilizing pro-
teins CBF-A or hnRNP A2, respectively. Brieﬂy, 6mlo f
jetPEI DNA transfection reagent (Polyplus-Transfection)
in 100ml of 150mM NaCl was added to equal volumes of
mixtures that had low or high ratios of CBF-A encoding
plasmid to the pFMR1-50-UTR(CGG)n-FL reporter
plasmid. Mixtures with a low ratio of CBF-A encoding
vector to reporter plasmid contained 500ng pFMR1-
50-UTR(CGG)n-FL (n=0, 30, 99); 0.05mg pCMV-RL
and 2.5mg pCMV2-Flag CBF-A in 150mM NaCl.
Similarly composed mixtures with a high ratio of
CBF-A encoding vector to pFMR1-50-UTR(CGG)n-FL
(n=0 or 99) reporter plasmid contained 50ng of
pFMR1-50-UTR(CGG)n-FL (n=0 or 99) and 2.9mg
pCMV-Flag CBF-A and 5ng pCMV-RL. Mixtures with
a low amount of hnRNP A2 encoding vector to the repor-
ter plasmid contained 250ng pFMR1-50-UTR(CGG)n-FL
(n=0, 30, 99) and 2.75mg pCMV-Flag-hnRNP A2
and 25ng pCMV-RL. Following incubation at 378C
for 2h, each plate was supplemented with 2.0ml of
growth medium and 1.0mM TMPyP4 was added as spe-
ciﬁed tosome plates to a ﬁnal concentration of 20mM.
The described procedure allowed for transfection eﬃ-
ciency of >90% as assessed by parallel monitoring GFP
expression in cells that were similarly transfected with a
GFP bearing vector. The cells were harvested 24h post-
transfection using Trypsin–EDTA and resuspended in
1.0ml of cold growth medium. Aliquots of each sample
were used to determine FL and RL activities and to con-
duct semi-quantitative reverse transcriptase (RT)–PCR
measurements of the levels of their mRNA transcripts
(see below).
Corrections for variations in cell viability and transfec-
tion eﬃciency were performed for each experiment as
described (19) except that the RL-corrected FL activity
was normalized to FL activity of cells transfected with
reporter pFMR1-50-UTR-FL vector with no upstream
(CGG) repeat tract. Transfection eﬃciencies, as assessed
by the measured levels of RL protein activity and RNA,
were consistently unaﬀected by the size of the (CGG)n
tract in the co-transfected pFMR1-50-UTR(CGG)n-FL
plasmid. Thus, for instance, in a typical series (N=5)of
RL measurements in cells that were co-transfected with an
FL plasmids with no (CGG)n tract or with a (CGG)99
repeat, the respective average values of RL protein activity
were 14045 5360 and 16615 4010 luminescence units
and the measured levels of RL RNA were, respectively,
2082 865 and 1832 900 phosphor image pixels.
Dual luciferase assay
FL and RL activities were determined in lysates of trans-
fected HEK293 cells according to the manufacturer’s
instructions using the dual luciferase reporter assay
system (Promega). Brieﬂy, the cells were lysed in passive
lysis buﬀer (Promega) and 40ml of cell lysate were added
to 50ml luciferase reagent II. Following a 2s delay, FL
activity was measured for 10s in a Glomax 20/20 lumin-
ometer. The reaction was terminated by adding 50ml Stop
and Glo reagent to quench the FL activity and following a
2s delay, the activity of RL was determined for 10s.
Semi-quantitative RT–PCR measurement ofrelative
mRNA levels
Total cell RNA was isolated from HEK-293 cells 24h
after transfection using Total RNA puriﬁcation kit
(Norgen Biotech Corporation). Contaminating plasmid
and genomic DNA were removed from the isolated
RNA by use of Turbo DNA-free kit (Ambion). For
each sample, 0.5mg of RNA was reverse-transcribed
with Verso cDNA kit (Thermo Fisher Scientiﬁc) employ-
ing anchored Oligo-dT primers. To verify that all the
ampliﬁcation products were copies of the RNA template
and not of contaminating DNA, every set of reactions
included a negative control of a mixture without RT.
After ﬁrst-strand synthesis, the product cDNA was quan-
tiﬁed by performing semi-quantitative PCR reaction. Each
reaction mixture contained in a ﬁnal volume of 25ml:
0.025mg cDNA; 0.3mCi [a-
32P] dCTP (3000Ci/mmol,
Amersham) and 5.0pmol each of the respective
FL forward and reverse primers; 50-d(GCTCCAACACC
CCAACATCT)-30 and 50-d(TTTCTTGCGTCGAGTT
TTCC)-30 or the respective RL forward and reverse
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AG)-30 and 50-d(CAATTTGTACAACGTCAGGTTTAC
CACC)-30. Measured levels of radiolabelled FL and RL
reverse transcripts for each cycle between the 25th and
32th cycles showed the 27th or 30th to be the mid-points
of the respective linear ampliﬁcation range of FL and RL
RNA. Twice repeated and averaged standard PCR proce-
dures were conducted with FL or RL cDNA for 27 or 30
cycles, respectively, each of 20s at 948C followed by 25s at
588C and 1min at 728C. To verify that the ampliﬁcation
products were authentic FL or RL DNA and not copies
of contaminating DNA, every set of reactions included
a negative control reaction mixture that lacked ﬁrst-
strand cDNA.
Western analysis
HEK293 cells that were co-transfected with pCMV2-
Flag-CBF-A or pCMV2-Flag-hnRNP A2 and pFMR1-
50-UTR(CGG)n-FL (n=0, 30 or 99) without or with
exposure to TMPyP4 as speciﬁed, were harvested 24h
after the transfection and lysed. Equal amounts of the
cell lysate protein were resolved by 10% SDS–PAGE,
transferred to nitrocellulose membrane and the expression
of Flag-CBF-A or Flag hnRNP A2 was detected by a
murine anti-Flag primary antibody (Sigma) with horse-
radish peroxidase-conjugated goat anti mouse IgG
(H+L, Pierce) serving as the secondary antibody (19).
Horseradish peroxidase activity was monitored using a
Super We Pico chemiluminescence substrate (Pierce).
RESULTS
TMPyP4 untangles invitro an intramolecular quadruplex
structure of r(CGG)33
We reported previously that a (CGG)33 repeat sequence
within an RNA transcript of pCS107(CGG)33 formed in
aK
+ ion-dependent reaction a compact, T1 ribonuclease
resistant secondary structure whose properties were con-
sistent with those of an intramolecular quadruplex (19).
In a parallel line of investigation we found that the catio-
nic porphyrin TMPyP4 destabilized in vitro bimolecular
tetraplex (CGG)n structures in DNA and RNA (25).
Here we inquired whether TMPyP4 was also capable of
unfolding an intramolecular r(CGG)n quadruplex. To this
end,
32P-labelled RNA transcript of pCS107(CGG)33 was
incubated without or with 5.0mM TMPyP4 in the absence
of alkali ion or in the presence of 20mM of either KCl or
LiCl which, respectively, promote or do not support the
formation of stable quadruplex structures of DNA or
RNA. To assess the eﬀect of TMPyP4 on potential sec-
ondary structure of the pCS107(CGG)33 RNA, its electro-
phoretic mobility in a non-denaturing agarose gel was
compared to the migration of marker pCS107 RNA that
lacked the repeat sequence. As seen in Figure 1, the mobil-
ity of the marker RNA molecules remained unaﬀected by
TMPyP4 in the absence of alkali ion or in the presence of
either KCl or LiCl. Similarly, TMPyP4 did not aﬀect the
electrophoretic migration of pCS107(CGG)33 RNA both
in the absence of salt or in a buﬀer that contained Li
+ ions
(Figure 1, left and right panels, respectively). In contrast,
the relative electrophoretic mobility of the (CGG)33 con-
taining RNA was increased in the presence of K
+ ions
and TMPyP4 slowed its migration (Figure 1, middle
panel). At the same time, the mobility of the pCS107
RNA that did not contain a (CGG) repeat tract remained
unchanged in the presence of K
+ ions without or with
TMPyP4. Thus, the likeliest cause of the slowed relative
electrophoretic mobility of the pCS107(CGG)33 RNA was
the unfolding by TMPyP4 of a rapidly migrating compact
intramolecular secondary structure of the r(CGG)33 tract.
Potassium ions are essential for the formation and stabil-
ity of quadruplex nucleic acids whereas lithium is unable
to promote its generation and stability (26,27). Hence,
the ability of TMPyP4 to slow the mobility of
pCS107(CGG)33 in K
+-containing buﬀer but not in the
presence of Li
+ ions conforms with a suggestion that the
compact structure of pCS107(CGG)33 was a quadruplex.
Yet, the possibility that the compact RNA formation
represented a diﬀerent secondary structure such as hairpin
cannot be excluded (see ‘Discussion’ section).
TMPyP4 enhances thetranslation invitro of (CGG)99-FL
mRNA
Evidence indicated that translation was impeded by quad-
ruplex structures of a FXS premutation (CGG)n stretch in
mRNA (19) and by tetraplex formations of G-rich tracts
in various other mRNA molecules (20–22). We thus
Figure 1. TMPyP4 destabilizes in vitro a secondary structure of 50-(CGG)33 containing RNA. Equal amounts of
32P-labelled 365-nt-long
pCS107(CGG)33 RNA transcript were resolved by electrophoresis through a non-denaturing 0.6% agarose gel next to
32P-labelled 339-nt-long
marker pCS107 RNA transcript that lacked a (CGG)33 tract. The RNA samples were pre-incubated at 48C for 20min in the absence or presence
of 1.6mM TMPyP4 and with or without 20mM of KCl or LiCl followed by their electrophoresis in gels that, respectively, were devoid of salt or
contained 20mM of either KCl or LiCl. Shown are phosphor images of the dried gels.
Nucleic Acids Research,2009, Vol.37, No. 8 2715inquired whether by virtue of its capability to unfold
quadruplex r(CGG)n, TMPyP4 was also able to remove
the obstruction to translation. Equal amounts of mRNA
transcripts of pT7FMR1-50-UTR(CGG)30-FL or
pT7FMR1-50-UTR(CGG)99-FL that, respectively,
included normal or premutation numbers of (CGG)
repeats were translated in a reticulocyte lysate system
that contained rising concentrations of TMPyP4.
Determination of the relative activity of FL indicated
that translation of pT7FMR1-50-UTR(CGG)30-FL
mRNA was only minimally enhanced in the presence of
increasing amounts of TMPyP4. In contrast, the transla-
tion of pT7FMR1-50-UTR(CGG)99-FL mRNA was aug-
mented up to >3-fold in direct proportion to the
concentration of added TMPyP4 (Figure 2A). These
results were in line with the reported minimal eﬀect of
the quadruplex unfolding proteins hnRNP A2 and CBF-
A on the in vivo translation of (CGG)30-FL mRNA and
their robust stimulation of the translation of premutation
(CGG)99-FL mRNA (19). Results presented in Figure 2B
showed that in contrast to the stimulation of the transla-
tion of (CGG)99-FL mRNA by TMPyP4, protein synthe-
sis was slightly depressed by its two positional isomers
TMPyP2 and TMPyP3 that were shown to be incapable
of destabilizing quadruplex r(CGG)n (25). Conceivably,
therefore, the enhancement of FL synthesis by TMPyP4
was a consequence of its ability to destabilize a translation
blocking r(CGG)99 quadruplex structure at the 50 UTR
terminus of the FL mRNA.
The quadruplex(CGG)ndestabilizing agentsTMPyP4
andCBF-A increase theefficiency ofthe invivo
translation of(CGG)99-FL mRNA
We next inquired whether TMPyP4 alone or in combina-
tion with tetraplex r(CGG)n unfolding hnRNPs might
increase the eﬃciency of the in vivo translation of premu-
tation (CGG)n mRNA. To this end we ﬁrst deﬁned exper-
imental conditions under which separately introduced
agents, TMPyP4 or CBF-A, aﬀected the eﬃcacy of trans-
lation of (CGG)99-FL mRNA in living cells. Since the
amount of (CGG)99-FL mRNA was proportional to the
amount of transfecting reporter plasmid (data not shown),
we empirically determined conditions for the introduction
of TMPyP4 or CBF-A at low or high ratios to the reporter
plasmids and consequently to their mRNA transcripts.
Matched cultures of HEK293 cells were co-transfected
with either pFMR1-50-UTR(CGG)0-FL or pFMR1-
50-UTR(CGG)99-FL reporter plasmids and with a
pCMV-RL normalizing vector. The transfected cells
were either exposed to TMPyP4 or were co-transfected
with the CBF-A expressing vector pCMV2-Flag CBF-A.
Control cells were transfected with reporter and normal-
izing plasmids but were not exposed to either TMPyP4 or
CBF-A. Following a 24h period of growth, the cells were
lysed and RL-normalized levels of FL activity and FL
mRNA were measured in the cell lysates. Table 1 sum-
marizes the results of multiple independent determinations
of the levels of FL protein and mRNA obtained in cells
that expressed (CGG)99-FL mRNA relative to similarly
treated cells that expressed (CGG)0-FL mRNA. As is evi-
dent, the respective eﬃciency of the in vivo translation
of (CGG)99-FL mRNA was increased by 2.8- or 3.2-fold
when TMPyP4 or CBF-A were introduced at apparent
excess over the reporter plasmid. Yet, no signiﬁcant
enhancement was observed when either agent was intro-
duced at what were conceivably their sub-saturating
amounts relative to the level of the (CGG)99-FL mRNA
(Table 1).
Notably, the elevated amount of premutation mRNA
was decreased upon exposure of the cells to high relative
doses of TMPyP4 or CBF-A (Table 1). This eﬀect raised
the possibility that in addition to being able to increase the
eﬃciency of premutation mRNA translation, these agents
might alleviate the presumed toxicity of premutation
FMR1 mRNA in FXS carrier cells by depressing its exces-
sive accumulation (see ‘Discussion’ section).
High relative amounts ofTMPyP4 togetherwithCBF-A
additively increasethe efficiency ofthe invivo
translation of (CGG)99-FLmRNA
A previous report (19) and results presented in Table 1
indicated that the eﬃcacy of the in vivo translation of
(CGG)99-FL mRNA was increased when cells expressed
high relative amounts of CBF-A or when they were
Figure 2. TMPyP4, but not TMPyP2 or TMPyP3, enhances the in vitro translation of (CGG)99-FL mRNA. (A) Equal amounts of
32P-labelled
mRNA transcripts of pT7-FMR1-50-UTR(CGG)n-FL (n=30 or 99) were translated in vitro in a reticulocyte lysate system that contained increasing
amounts of TMPyP4 and the activity of FL was determined as described under ‘Materials and Methods’ section. Presented are end-points of each
reaction. (B) FL activity produced by the in vitro translation of (CGG)99-FL mRNA in the presence of the indicated increasing amounts of the
positional isomers TMPyP2, TMPyP3 or TMPyP4. Shown are end-points of each reaction.
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results we examined the eﬀect of combining high relative
levels of TMPyP4 and the quadruplex unfolding CBF-A
protein on the eﬃcacy of the in vivo translation of
(CGG)99-FL mRNA. HEK293 cells were transfected
with 50ng of either pFMR1-50-UTR(CGG)0-FL or
pFMR1-50-UTR(CGG)99-FL reporter plasmids and with
a pCMV-RL normalizing vector. Parallel cultures were
exposed to 20mM TMPyP4, co-transfected with 2.9mg
pCMV2-Flag CBF-A plasmid or were both treated with
TMPyP4 and co-transfected with pCMV2-Flag-CBF-A.
The selected high relative ratios of TMPyP4 or CBF-A
encoding vector to the reporter FL plasmid were those
indicated in the respective section of Table 1. Cells were
grown for 24h, lysed and RL normalized levels of FL
activity and FL mRNA were determined in lysates of
the diﬀerently treated cells and in control cells that were
transfected by the respective reporter plasmids but
were not exposed to any quadruplex unfolding agent.
The relative translation eﬃcacies in the absence or pres-
ence of quadruplex destabilizing agents were assessed
by measuring the ratio of expressed FL protein activity
to FL mRNA. Results shown in Figure 3 show the trans-
lation eﬃciencies of (CGG)99-FL mRNA relative to eﬃ-
ciencies of translation of (CGG)0-FL mRNA in equally
treated cells.
The obtained data indicated that the relative eﬃciency
of translation of (CGG)99-FL mRNA in cells that were
Figure 3. High relative amounts of TMPyP4 and CBF-A cooperate to additively increase the in vivo eﬃciency of translation of (CGG)99-FL mRNA.
HEK293 cells were transfected with 50ng of either pFMR1-50-UTR(CGG)0-FL or pFMR1-50-UTR(CGG)99-FL reporter plasmids and with a pCMV-
RL normalizing vector. Matched cultures were exposed to 20 mM TMPyP4, co-transfected with 2.9mg pCMV2-Flag CBF-A plasmid or were both
treated with TMPyP4 and co-transfected with pCMV2-Flag-CBF-A. Following cell growth, levels of FL activity and mRNA were determined as
described under ‘Materials and Methods’ section and in Table 1. Tabulated are average values   SD of the indicated number (N) of independent
determinations of the translation eﬃciency, (FL activity divided by FL mRNA), of (CGG)99-FL mRNA relative to (CGG)0-FL mRNA. Bottom:
Graphic presentation of the results.
Table 1. Eﬀect of diﬀerent relative levels of TMPyP4 and CBF-A on the eﬃciency of the in vivo translation of (CGG)99-FL mRNA
Agent Low ratio of agent to pFMR1-50-UTR(CGG)99-FL
a High ratio of agent to pFMR1-50-UTR(CGG)99-FL
b
FL
protein
FL
mRNA
FL protein/
mRNA [N]
c
X-fold increase of
translation eﬃcacy
FL
protein
FL
mRNA
FL protein/
mRNA [N]
c
X-fold increase of
translation eﬃcacy
– 4.9 1.0 6.3 1.9 0.8 [9] 1.0 4.6 0.1 8.2 2.7 0.6 [5] 1.0
TMPyP4 4.8 1.0 5.8 1.0 0.8 [8] 1.0 5.2 0.7 3.1 0.4 1.7 [4] 2.8
CBF-A 8.8 1.2 8.6 1.6 1.0 [5] 1.25 9.3 1.9 5.0 2.1 1.9 [4] 3.2
Listed are average levels and standard deviations of the of FL protein and mRNA relative to values obtained for HEK293 cells that were transfected
with pFMR1-50-UTR(CGG)0-FL reporter plasmid and that were similarly exposed to TMPyP4, co-transfected with a CBF-A expressing plasmid or
left untreated.
a5 10
5 HEK293 cells were transfected with 500ng DNA of a pFMR1-50-UTR(CGG)99-FL reporter plasmid were either exposed to 20mM TMPyP4
or co-transfected with 2.5mg DNA of a CBF-A expressing pCMV2-Flag-CBF-A vector.
b5 10
5 HEK293 cells were transfected with 50ng DNA of a pFMR1-50-UTR(CGG)99-FL reporter plasmid were either exposed to 20mM TMPyP4
or co-transfected with 2.9mg DNA of a CBF-A expressing pCMV2-Flag-CBF-A vector.
cN: number of independent experiments.
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tively, increased by 2.8- or 3.2-fold. Introduction of a
combination of the two quadruplex destabilizing agents
together increased the relative eﬃcacy of translation by
5.2-fold (Figure 3). Thus, the magnitude of the stimulation
that was attained in the presence of both TMPyP4 and
CBF-A was nearly a sum of the enhancement by each
agent separately. The additive eﬀect of combining
TMPyP4 with CBF-A suggested that the two agents
shared a common mechanism of translation augmentation
(see ‘Discussion’ section).
Combinationof low relative amountsof TMPyP4 and
CBF-Asynergistically increases thein vivoefficiency of
translation of(CGG)99-FL mRNA
Although sub-saturating levels of TMPyP4 or CBF-A
each failed to raise the eﬃcacy of the in vivo translation
of premutation (CGG)99-FL mRNA (Table 1), we
speculated that combining the two agents might
increase the translation eﬃciency of premutation
(CGG)99 mRNA. To examine this possibility, matched
HEK293 cell cultures were co-transfected with 500ng of
pFMR1-50-UTR(CGG)n-FL (n=0, 30 or 99) reporter
plasmids and a pCMV-RL normalizing vector. Parallel
to transfected control cells that were left untreated,
matching cultures were exposed to 20mM TMPyP4,
co-transfected with 2.5mg pCMV2-Flag CBF-A or treated
by a combination thereof. The chosen low relative ratios
of TMPyP4 or CBF-A expressing vector to the reporter
FL plasmid were those indicated in the respective section
of Table 1. Following a 24h growth period, the cells
were harvested and lysed and RL-normalized levels of
expressed FL protein and mRNA were determined.
Relative translation eﬃcacies were calculated by dividing
the measured eﬃciencies of translation of (CGG)30 or
(CGG)99 containing mRNA by the values obtained for
(CGG)0 mRNA in similarly treated cells.
Western analysis indicated that CBF-A expression was
maintained at an unchanged level regardless of the
number of (CGG) repeats in the FL reporter vector or
the absence or presence of TMPyP4 (Figure 4A).
However, combining TMPyP4 with CBF-A aﬀected dif-
ferently the relative translation eﬃcacies of FL mRNA
molecules that contained 30 or 99 (CGG) repeats. In
line with our previous report (19), (CGG)30-FL mRNA
Figure 4. Low relative amounts TMPyP4 and CBF-A cooperate to synergistically increase the in vivo eﬃciency of translation of (CGG)99-FL mRNA.
(A) Western blot analysis of CBF-A expression in HEK293 cells that were co-transfected with 2.5 mg DNA of CBF-A expressing plasmid and 500ng
DNA of reporter FL plasmid that contained 30, 99 or no (CGG) repeats and that were or were not exposed to 20mM TMPyP4. (B) Relative
translation eﬃciencies of (CGG)0-FL mRNA, (CGG)30-FL mRNA or (CGG)99-FL mRNA without or in the presence of sub-saturating amount of
TMPyP4 or CBF-A alone or a combination thereof. Displayed are average results   SD of the indicated number (N) of independent experiments.
(C) Graphic presentation of results tabulated in (B).
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mRNA with no repeat tract (Figure 4B and C). This
level of (CGG)30-FL mRNA utilization was not aﬀected
by either the expression of sub-saturating amounts of
CBF-A or the addition of TMPyP4. A slight enhancement
of the translation eﬃciency observed upon introduction of
both agents together was not statistically signiﬁcant
(Figure 4B and C). As reported (19), the presence of a
premutation 50-UTR (CGG)99 repeat sequence in FL
mRNA depressed its utilization relative to FL mRNA
molecules with no repeat tract and particularly relative
to (CGG)30 containing mRNA (Figure 4B and C).
Furthermore, this diminished eﬃciency of translation
was not elevated by sub-saturating amounts of either
TMPyP4 or CBF-A. Most conspicuously, however, cells
that expressed sub-saturating amounts of CBF-A and
were also exposed to low relative concentration of
TMPyP4 utilized (CGG)99-FL mRNA at >5-fold greater
eﬃciency than cells that were not exposed to any quad-
ruplex unfolding agent (Figure 4B and C). Hence, apply-
ing to cells a combination of sub-saturating amounts of
TMPyP4 and CBF-A that are not eﬀective by themselves,
resulted in synergistic enhancement of the eﬃciency of
translation of (CGG)99-FL mRNA.
The efficiency ofthe in vivotranslation of (CGG)99-FL
mRNA isalso increased synergistically by combining
low relative amountsof hnRNP A2and TMPyP4
Similarly to CBF-A, hnRNP A2 was shown to be capable
of unfolding in vitro quadruplex structures of (CGG)n in
DNA and RNA (18) and to increase the eﬃcacy of the
in vivo translation of premutation (CGG)99 mRNA (19).
We next inquired whether the synergistic enhancement of
translation by TMPyP4 in combination with CBF-A can
be reproduced by replacing CBF-A with hnRNP A2. In
preparatory experiments similar to those summarized in
Table 1, we deﬁned high and low ratios of hnRNP A2
expressing vector to FL reporter plasmid that, respec-
tively, enhanced the translation of (CGG)99-FL mRNA
or elicited no eﬀect (data not shown). In the following
experiment we expressed hnRNP A2 at ineﬀective low rel-
ative ratio relative to the reporter plasmids. Matched
HEK293 cell cultures were co-transfected with 250ng
of pFMR1-50-UTR(CGG)n-FL (n=0, 30 or 99)
reporter plasmids and a pCMV-RL normalizing vector.
Transfected control cells were left untreated whereas
parallel cultures were exposed to 20mM TMPyP4,
co-transfected with 2.75mg DNA of the hnRNP A2
expressing vector pCMV2-Flag hnRNP A2 or treated by
a combination of both agents. Cells were grown and lysed
and RL-normalized relative levels of FL activity and
mRNA were measured as described in the preceding sec-
tion. Western analysis indicated that the expression of
hnRNP A2 was unaﬀected by the number of (CGG)
repeats in the reporter plasmid or by the absence or pres-
ence of TMPyP4 (Figure 5A). Results indicated that the
eﬃciency of translation of (CGG)30-FL mRNA was ele-
vated by 2-fold relative to FL mRNA with no repeat tract
and that exposure to sub-saturating doses of TMPyP4 or
hnRNP A2 or to a combination thereof did not
signiﬁcantly alter its eﬃciency of translation (Figure 5B
and C). In contrast, as documented (Table 1, Figures 3
and 4), the presence of 99 50-(CGG) repeats in FL mRNA
depressed the eﬃciency of its translation. Also, this dimin-
ished eﬃcacy was not elevated by separately introduced
sub-saturating amounts of TMPyP4 or hnRNP A2.
However, the translation eﬃciency of (CGG)99-FL
mRNA was higher by 1.4–1.9-fold in cells that were
exposed to a combination of sub-saturating amounts of
TMPyP4 together with hnRNP A2 (Figure 5B and C).
Thus, similarly to CBF-A, sub-saturating levels of
hnRNPA2 cooperated with low relative amounts of
TMPyP4 to synergistically increase the eﬃciency of the
in vivo translation of mRNA molecules that included a 50
(CGG)99 premutation tract.
DISCUSSION
Expansion of the FMR1 50-UTR repeat tract to >55–200
copies of the (CGG) trinucleotide causes, in subgroups of
female and male carriers of FXS premutation, respective
development of POF (4,6) and of FXTAS (7–9). Although
the premutation state is characterized by elevated synthe-
sis and accumulation of 5–10-fold higher than normal
amounts of FMR1 mRNA molecules (10–12), levels of
their product protein FMRP are reduced or remain
unchanged (11,14). We have shown recently that impedi-
ment to translation by quadruplex structures of the
50-UTR (CGG)>55–200 premutation tract in FMR1
mRNA is the likely source of the apparent diminished
eﬃcacy of FMRP synthesis (19). Also, over-expression
in living cells of two d/r(CGG)n quadruplex destabilizing
hnRNPs; CBF-A and hnRNP A2, (18,19,28,29) removed
the obstruction to translation and reinstated normal eﬃ-
ciency of premutation mRNA utilization (19). This ﬁnding
suggested that quadruplex (CGG)n unfolding agents may
be useful in partly overcoming the molecular defect in cells
of premutation carriers. However, therapeutic utilization
of exogenously introduced proteins such as CBF-A or
hnRNP A2 is impractical and a more realistic option is
the use of small quadruplex destabilizing molecules. We
thus chose to examine the cationic porphyrin TMPyP4
that, contrary to its capability to stabilize quadruplex
structures of the telomeric repeat (23,25,30) and of a gua-
nine-rich tract in the c-Myc promoter (24), was shown to
paradoxically destabilize d(CGG)n quadruplexes (25).
In the present work we ﬁrst demonstrated that TMPyP4
unfolded in vitro an intramolecular secondary structure
of an r(CGG)33 tract (Figure 1). Since RNA that did
not contain r(CGG)33 repeat tract was unaﬀected by
TMPyP4 and as the untangled pCS107(CGG)33 RNA sec-
ondary structure was generated in the presence of K
+ but
not Li
+ ions, we propose that it represented a quadruplex.
In such case, similarly to its reported ability to resolve
in vitro a formally deﬁned bimolecular tetraplex structure
of r(CGG)n (25), TMPyP4 appeared to be able to unfold
in vitro an intramolecular quadruplex form of the RNA
repeat sequence. It should be cautioned, however, that
although previous additional indirect evidence also indi-
cated that (CGG)n RNA formed an intramolecular
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r(CGG)33 secondary structure is still lacking.
TMPyP4, but not its positional isomers TMPyP2 or
TMPyP3 that are unable to unfold quadruplex (CGG)n
(25), enhanced the translation in reticulocyte lysate of a
premutation-like reporter (CGG)99-FL mRNA (Figure 2).
Based on these ﬁndings we compared the ability of
TMPyP4 or of the quadruplex unfolding proteins CBF-
A and hnRNP A2 to increase the eﬃciency of the in vivo
translation of premutation (CGG)99-FL mRNA. Our
initial results indicated that exposure of HEK293 cells
to TMPyP4, at empirically determined excess over the
pFMR1-50-UTR(CGG)99-FL transfecting reporter plas-
mid, elevated the eﬃciency of (CGG)99-FL mRNA trans-
lation (Table 1). The extent of TMPyP4-induced
stimulation was comparable to the enhancement of
in vivo translation by CBF-A [Table 1; (20)]. In contrast,
lower amounts of TMPyP4, CBF-A or hnRNP A2 relative
to the reporter pFMR1-50-UTR(CGG)99-FL plasmid
failed to increase the eﬃciency of (CGG)99-FL mRNA
translation (Table 1 and Figure 5). Since the amount of
(CGG)99-FL mRNA was proportional to the amount of
transfecting reporter plasmid, it appeared that in order
to enhance translation both TMPyP4 and CBF-A had
to be present at an excess over the premutation mRNA.
The required TMPyP4 to RNA stoichiometry and the
non-catalytic quadruplex nucleic acid destabilizing activity
of CBF-A (18,19,28,29) suggested that the two agents
had a similar mechanism of action. Data summarized in
Figure 3 that demonstrated additive augmentation of
translation eﬃcacy by TMPyP4 and CBF-A was indeed
supportive of the supposition that these agents shared a
similar mechanism of destabilization of quadruplex
(CGG)n structure in premutation mRNA. Conceivably,
both the cationic porphyrin and CBF-A recognized
G-quartets that were formed within the (CGG)n sequence,
bound to the quadruplex domain and diminished its sta-
bility, as reﬂected by the capacity of TMPyP4 to lower the
melting temperatures of tetraplex (CGG)n (25).
Our results indicated that the eﬃcacy of translation of
(CGG)30-FL mRNA was up to 3-fold higher than that of
(CGG)0-FL mRNA (Figures 4B and 5B). A 50-(CGG)30
tract represents the most common number of (CGG)
repeats in the FMR1 gene in the normal human popula-
tion (31). It may be speculated that this size of the repeat
sequence was evolutionarily conserved because it aﬀords
higher eﬃcacy of FMRP synthesis, possibly by attracting
translation factors to the FMR1 mRNA. Notably, how-
ever, the quadruplex disrupting agents TMPyP4, CBF-A
or hnRNP A2 each by themselves or TMPyP4 together
Figure 5. Low relative amounts TMPyP4 and hnRNP A2 cooperate to synergistically increase the in vivo eﬃciency of translation of (CGG)99-FL
mRNA. (A) Western blot analysis of hnRNP A2 expression in HEK293 cells that were co-transfected with 2.75 mg DNA of hnRNP A2 expressing
plasmid and 250ng DNA of reporter FL plasmid that contained 30, 99 or no (CGG) repeats and that were or were not exposed to 20 mM TMPyP4.
(B) Relative translation eﬃciencies of 50UTR (CGG)0-FL mRNA 50UTR (CGG)30-FL mRNA or 50UTR (CGG)99-FL mRNA without or in the
presence of sub-saturating amount of TMPyP4 or hnRNP A2 alone or a combination thereof. Displayed are average results   SD of the indicated
number (N) of independent experiments. (C) Graphic presentation of results tabulated in (B).
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translation of (CGG)30-FL mRNA (Figures 4B and 5B).
We assume, therefore, that unlike a quadruplex structure
of a premutation-size 50-(CGG)99 tract, the shorter
50-(CGG)30 sequence either did not block translation or
it even promoted it. Alternatively, the 50-(CGG)30 stretch
may have been unstable at 378C within the cells such that
it was maintained as a single-strand also in the absence
of quadruplex destabilizing agents.
Introduction of excessive amounts of TMPyP4 or of
greatly over-expressed quadruplex disrupting hnRNPs is
likely to be therapeutically impractical. Presented evidence
showed, however, that although low relative amounts of
these agents failed to stimulate by themselves the in vivo
translation of (CGG)99-FL mRNA, combining TMPyP4
with CBF-A (Figure 4) or with hnRNP A2 (Figure 5)
elicited signiﬁcant increases in the eﬃcacy of translation
of the premutation mRNA. The inability of a low relative
dose of TMPyP4 to enhance by itself the translation of
(CGG)99-FL mRNA suggested that the levels of available
endogenous CBF-A and hnRNP A2 in HEK293 cells were
insuﬃcient to cooperate with the externally added
TMPyP4. It is possible however, that TMPyP4 alone
may suﬃce to enhance the translation of premutation
mRNA in other cell types that endogenously produce
higher amounts of hnRNPs.
It has been suggested that the source of neurodegenera-
tion in FXTAS is the accumulation of excessive amounts
of premutation FMR1 mRNA in FXS carrier cells.
A proposed RNA gain-of-function toxicity model sug-
gested that the accumulated FMR1 mRNA molecules
bind r(CGG) repeat binding proteins (RBPs) that are
thus sequestered from their normal functions (32,33).
Interestingly, hnRNP A2/B1 was recently identiﬁed as a
major RBP in a transgenic Drosophila model of FXTAS
(34,35), providing independent evidence for the in vivo
interaction of this quadruplex r(CGG)n disrupting protein
with the premutation repeat tract. In addition to its asso-
ciation with premutation (CGG)n mRNA and its capacity
to enhance its translation, over expressed hnRNP A2 was
shown to diminish the amount of the accumulated mRNA
(19). Data presented in this manuscript indicated that the
elevated amount of premutation mRNA was also reduced
in cells that were exposed to TMPyP4 or to CBF-A
(Table 1 and Figure 4). It should be noted that both
agents had to be introduced in excess over the (CGG)99-
FL mRNA. Introduction of TMPyP4, CBF-A or hnRNP
A2 alone, each at low ratio relative to the premutation
mRNA, did not decrease the level of (CGG)99-FL
mRNA (Table 1, Figures 4 and 5). Only combinations
of low ratios of the porphyrin with either CBF-A or
hnRNP A2 depressed mRNA accumulation. Low ratios
of the quadruplex disrupting porphyrin or hnRNPs by
themselves to premutation mRNA also failed to elicit
enhancement of translation whereas combinations of
TMPyP4 with either protein both augmented the transla-
tion of 50-(CGG)99-mRNA and depressed its accumula-
tion (Table 1, Figures 4 and 5). It is tempting, therefore,
to implicate the quadruplex destabilizing activity of the
proteins and TMPyP4 in both translation enhancement
and lowering of the level of premutation mRNA. In any
case, whatever the mechanism is by which TMPyP4 and
the two hnRNPs depressed mRNA accumulation,
our observations suggested that in addition to being
able to increase the eﬃciency of premutation mRNA
translation, these agents may also be eﬀective in decreas-
ing the RNA toxicity in cells of FXS carriers.
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